A new clinical trial with lots of hope.
We went to see Dr. Haverokos at UC Health Ashutz Campus yesterday morning. I was nervous because he has been very clear in the past that "people don't wait with this diagnosis," and "you'll be worse next time I see you." He's a very likable person so it's been easy to give him a pass on these kind of messages. After all, he believes them, I'm sure, so who can fault him. Yesterday he was wearing a mask, which led us to a discussion that he and his wife are expecting their first and only child. It was fun to celebrate exciting news with him. After all the greetings, he started to tell us that he has been running an ongoing clinical trial, investigating a pair of drugs that seem to be well tolerated - better tolerated than the other HDAC inhibitors I've tried. (Like Belinostat and Romedepsin). The two drugs use what they call a "Kick and Kill Strategy," whereby an antiviral medication goes after the Epstein Barr Virus in the tumor, a...